dimethyl sulfoxide has been researched along with Stroke in 11 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stroke was induced in rats by embolizing a preformed clot into the middle cerebral artery." | 5.34 | Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. ( Allahtavakoli, M; Pourshanazari, A; Roohbakhsh, A; Shabanzadeh, A, 2007) |
| "The safety and tolerability of a free radical scavenger with Na+ channel blocking activity (dimethyl sulfoxide (DMSO)) combined with a glycolytic intermediate and high energy substrate (fructose 1,6-disphosphate (FDP)) were assessed in a mostly elderly patient group presenting with acute and subacute ischemic stroke." | 5.10 | Ischemic stroke in elderly patients treated with a free radical scavenger-glycolytic intermediate solution: a preliminary pilot trial. ( de la Torre, JC; Demir, S; Karaça, M; Kiliç, E; Yazici, B, 2002) |
| "Endovascular occlusion of cerebral arteriovenous malformations (AVM) is often utilized as adjunctive therapy in combination with radiosurgery or microsurgery." | 2.50 | Embolization-induced angiogenesis in cerebral arteriovenous malformations. ( Buell, TJ; Ding, D; Liu, KC; Starke, RM; Webster Crowley, R, 2014) |
| "Neurobehavioral testing, infarct volume quantification, and hippocampal neuronal survival were employed to determine severity of stroke." | 1.91 | Post-stroke periodic estrogen receptor-beta agonist improves cognition in aged female rats. ( Bassett, ZQ; Bramlett, HM; Dave, KR; Patel, SH; Perez-Pinzon, MA; Pradhyumnan, H; Raval, AP; Reddy, V; Zhao, W, 2023) |
| "Vertebral arteriovenous fistulas (VAVF) are infrequent lesions characterized by abnormal communication of the extracranial vertebral artery or one of its branches to the surrounding venous plexuses, without the presence of any intervening vessels." | 1.40 | Spontaneous vertebral arteriovenous fistula causing cervical myelopathy and acute ischemic strokes treated by endovascular balloon-assisted coiling and Onyx embolization. ( Hui, F; Hussain, MS; Jaffari, N; John, S; Lu, M, 2014) |
| " The aim of this study was to clarify differences in outcomes owing to different dosing regimens and the pharmacokinetic profile of progesterone, particularly in relation to brain levels." | 1.38 | Progesterone pharmacokinetics in the mouse: implications for potential stroke therapy. ( Kendall, DA; Ray, D; Wong, R, 2012) |
| "Stroke was induced in rats by embolizing a preformed clot into the middle cerebral artery." | 1.34 | Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. ( Allahtavakoli, M; Pourshanazari, A; Roohbakhsh, A; Shabanzadeh, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Pradhyumnan, H | 1 |
| Reddy, V | 1 |
| Bassett, ZQ | 1 |
| Patel, SH | 1 |
| Zhao, W | 1 |
| Dave, KR | 1 |
| Perez-Pinzon, MA | 1 |
| Bramlett, HM | 1 |
| Raval, AP | 1 |
| Mirabet, V | 1 |
| García, D | 1 |
| Roca, A | 1 |
| Quiroz, AR | 1 |
| Antón, J | 1 |
| Rodríguez-Cadarso, M | 1 |
| Ocete, D | 1 |
| Aranda, L | 1 |
| Melero, A | 1 |
| Guillot, AJ | 1 |
| Yagüe, N | 1 |
| Guillén, I | 1 |
| Botella, C | 1 |
| John, S | 1 |
| Jaffari, N | 1 |
| Lu, M | 1 |
| Hussain, MS | 1 |
| Hui, F | 1 |
| Buell, TJ | 1 |
| Ding, D | 1 |
| Starke, RM | 1 |
| Webster Crowley, R | 1 |
| Liu, KC | 1 |
| Ichijo, M | 1 |
| Ishibashi, S | 1 |
| Li, F | 1 |
| Yui, D | 1 |
| Miki, K | 1 |
| Mizusawa, H | 1 |
| Yokota, T | 1 |
| González-López, TJ | 1 |
| Sánchez-Guijo, FM | 1 |
| Ortín, A | 1 |
| Crusoe, E | 1 |
| Cordoba, I | 1 |
| Corral, M | 1 |
| Vazquez, L | 1 |
| Caballero, MD | 1 |
| Wong, R | 1 |
| Ray, D | 1 |
| Kendall, DA | 1 |
| Chen-Plotkin, AS | 1 |
| Vossel, KA | 1 |
| Samuels, MA | 1 |
| Chen, MH | 1 |
| Savolainen, H | 1 |
| Allahtavakoli, M | 1 |
| Shabanzadeh, A | 1 |
| Roohbakhsh, A | 1 |
| Pourshanazari, A | 1 |
| Karaça, M | 1 |
| Kiliç, E | 1 |
| Yazici, B | 1 |
| Demir, S | 1 |
| de la Torre, JC | 1 |
1 review available for dimethyl sulfoxide and Stroke
| Article | Year |
|---|---|
Embolization-induced angiogenesis in cerebral arteriovenous malformations.
Topics: Antigens, CD; Cell Hypoxia; Cerebrovascular Circulation; Combined Modality Therapy; Dimethyl Sulfoxi | 2014 |
1 trial available for dimethyl sulfoxide and Stroke
| Article | Year |
|---|---|
Ischemic stroke in elderly patients treated with a free radical scavenger-glycolytic intermediate solution: a preliminary pilot trial.
Topics: Adult; Aged; Aging; Brain; Brain Edema; Cerebrovascular Circulation; Dimethyl Sulfoxide; Drug Combin | 2002 |
9 other studies available for dimethyl sulfoxide and Stroke
| Article | Year |
|---|---|
Post-stroke periodic estrogen receptor-beta agonist improves cognition in aged female rats.
Topics: Animals; Cognition; Dimethyl Sulfoxide; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; | 2023 |
Cranioplasty with Autologous Bone Flaps Cryopreserved with Dimethylsulphoxide: Does Tissue Processing Matter.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Autografts; Bone Resorption; Brain Edema; Brain Injuries, | 2021 |
Spontaneous vertebral arteriovenous fistula causing cervical myelopathy and acute ischemic strokes treated by endovascular balloon-assisted coiling and Onyx embolization.
Topics: Arteriovenous Fistula; Balloon Occlusion; Blood Vessel Prosthesis; Dimethyl Sulfoxide; Embolization, | 2014 |
Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke.
Topics: Animals; Dimethyl Sulfoxide; Disease Models, Animal; Endothelial Cells; Male; Mice; Oxadiazoles; Rec | 2015 |
Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs.
Topics: Cryopreservation; Cryoprotective Agents; Dimethyl Sulfoxide; Hematopoietic Stem Cell Transplantation | 2011 |
Progesterone pharmacokinetics in the mouse: implications for potential stroke therapy.
Topics: Animals; Brain; Dimethyl Sulfoxide; Enzyme-Linked Immunosorbent Assay; Half-Life; Infusion Pumps, Im | 2012 |
Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation.
Topics: Brain Injuries; Dimethyl Sulfoxide; Female; Humans; Male; Middle Aged; Myocardial Infarction; Stem C | 2007 |
Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation.
Topics: Dimethyl Sulfoxide; Heme; Humans; Hypoxia-Ischemia, Brain; Mitochondria; Myocardial Infarction; Stem | 2007 |
Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
Topics: Animals; Behavior, Animal; Blood Coagulation; Brain; Cerebral Infarction; Dimethyl Sulfoxide; Dizoci | 2007 |